skip to main |
skip to sidebar
"Analysts expect Pfizer to win approval for a first-of-a-kind drug to treat HIV despite safety concerns raised by government regulators ahead of a Tuesday meeting.
A panel of experts meets in Rockville, Md., to advise the Food and Drug Administration on whether to approve Pfizer's maraviroc to fight HIV. If approved it would be the first in a new class of treatments that block HIV from entering white blood cells through a pathway present in some patients that carry the virus."
